» Articles » PMID: 24625239

Effect of a 6-month Intervention with Cooking Oils Containing a High Concentration of Monounsaturated Fatty Acids (olive and Canola Oils) Compared with Control Oil in Male Asian Indians with Nonalcoholic Fatty Liver Disease

Overview
Date 2014 Mar 15
PMID 24625239
Citations 42
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: We investigated the effects of dietary intervention with canola or olive oil in comparison with commonly used refined oil in Asian Indians with nonalcoholic fatty liver disease (NAFLD).

Subjects And Methods: This was a 6-month intervention study including 93 males with NAFLD, matched for age and body mass index (BMI). Subjects were randomized into three groups to receive olive oil (n=30), canola oil (n=33), and commonly used soyabean/safflower oil (control; n=30) as cooking medium (not exceeding 20 g/day) along with counseling for therapeutic lifestyle changes. The BMI, fasting blood glucose (FBG) and insulin levels, lipids, homeostasis model of assessment for insulin resistance (HOMA-IR), HOMA denoting β-cell function (HOMA-βCF), and disposition index (DI) were measured at pre- and post-intervention. Data were analyzed with one-way analysis of variance (ANOVA) and Tukey's Honestly Significant Difference multiple comparison test procedures.

Results: Olive oil intervention led to a significant decrease in weight and BMI (ANOVA, P=0.01) compared with the control oil group. In a comparison of olive and canola oil, a significant decrease in fasting insulin level, HOMA-IR, HOMA-βCF, and DI (P<0.001) was observed in the olive oil group. Pre- and post-intervention analysis revealed a significant increase in high-density lipoprotein level (P=0.004) in the olive oil group and a significant decrease in FBG (P=0.03) and triglyceride (P=0.02) levels in the canola oil group. The pre- and post-intervention difference in liver span was significant only in the olive (1.14 ± 2 cm; P<0.05) and canola (0.66 ± 0.33 cm; P<0.05) oil groups. In the olive and canola oil groups, post-intervention grading of fatty liver was reduced significantly (grade I, from 73.3% to 23.3% and from 60.5% to 20%, respectively [P<0.01]; grade II, from 20% to 10% and from 33.4% to 3.3%, respectively [P<0.01]; and grade III, from 6.7% to none and from 6.1% to none, respectively). In contrast, in the control oil group no significant change was observed.

Conclusions: Results suggest significant improvements in grading of fatty liver, liver span, measures of insulin resistance, and lipids with use of canola and olive oil compared with control oils in Asian Indians with NAFLD.

Citing Articles

Exploring the Cardiovascular Benefits of Extra Virgin Olive Oil: Insights into Mechanisms and Therapeutic Potential.

Milena E, Maurizio M Biomolecules. 2025; 15(2).

PMID: 40001586 PMC: 11852600. DOI: 10.3390/biom15020284.


The impact of substituting clarified butter with canola oil on the components of metabolic syndrome, fatty liver index, and insulin resistance among individuals diagnosed with metabolic syndrome: a quasi-experimental study.

Sedgi F, Hosseiniazar M, Alizadeh M J Diabetes Metab Disord. 2024; 23(2):1977-1987.

PMID: 39610540 PMC: 11599835. DOI: 10.1007/s40200-024-01453-z.


The Role of Antioxidants in the Treatment of Metabolic Dysfunction-Associated Fatty Liver Disease: A Systematic Review.

Mohammadian K, Fakhar F, Keramat S, Stanek A Antioxidants (Basel). 2024; 13(7).

PMID: 39061866 PMC: 11273623. DOI: 10.3390/antiox13070797.


Gut microbes, diet, and genetics as drivers of metabolic liver disease: a narrative review outlining implications for precision medicine.

Hermanson J, Tolba S, Chrisler E, Leone V J Nutr Biochem. 2024; 133:109704.

PMID: 39029595 PMC: 11480923. DOI: 10.1016/j.jnutbio.2024.109704.


The Effects of Olive Oil Consumption on Biochemical Parameters and Body Mass Index of People with Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Tsamos G, Kalopitas G, Evripidou K, Vasdeki D, Koufakis T, Kanavas V Nutrients. 2024; 16(6).

PMID: 38542768 PMC: 10976078. DOI: 10.3390/nu16060857.